These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 14446533)

  • 1. [The effect of tertiary aliphatic phosphine derivatives on mouse ascites carcinoma].
    SIERING H
    Arzneimittelforschung; 1960 Apr; 10():229-31. PubMed ID: 14446533
    [No Abstract]   [Full Text] [Related]  

  • 2. SYNTHESIS OF HEXAHYDROAZEPINYL-BIS(AZIRIDINYL)PHOSPHINE OXIDE, SULFIDE, AND RELATED COMPOUNDS FOR CANCER THERAPY.
    TSOU KC; HOEGERLE K
    J Med Chem; 1963 Jan; 6():47-9. PubMed ID: 14174030
    [No Abstract]   [Full Text] [Related]  

  • 3. [The cytostatic effectiveness of tertiary aliphatic phosphine derivatives in chronic lymphatic leukemias].
    SIERING H
    Verh Dtsch Ges Inn Med; 1959; 65():215-8. PubMed ID: 14446532
    [No Abstract]   [Full Text] [Related]  

  • 4. PHOSPHORUS MUSTARDS. I. A NEW CLASS OF POTENTIAL ANTINEOPLASTIC AGENTS.
    ABBISS TP; SOLOWAY AH; MARK VH
    J Med Chem; 1964 Nov; 7():763-6. PubMed ID: 14262806
    [No Abstract]   [Full Text] [Related]  

  • 5. Nitrosourea derivatives of tertiary phosphine oxides.
    Gugova R; Varbanov S; Raikov Z; Demirov G; Todorov D; Ilarionova
    Pharmazie; 1991 Aug; 46(8):603. PubMed ID: 1798718
    [No Abstract]   [Full Text] [Related]  

  • 6. Tertiary phosphines and phosphine oxides containing a 2-haloethyl group.
    Struck RF; Shealy YF
    J Med Chem; 1966 May; 9(3):414-6. PubMed ID: 5960918
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of chemotherapeutic agents against a variety of mouse ascites tumors. III.
    RUTMAN RJ; LEWIS FS; BUCKNER S; PRICE CC; LLEWELLYN F; OWEN E
    Cancer Res; 1962 Aug; 22():559-608. PubMed ID: 14495504
    [No Abstract]   [Full Text] [Related]  

  • 8. [CONTRIBUTION TO THE CHEMICAL AND PHARMACOLOGICAL STUDY OF AZIRIDINYL PHOSPHINE OXIDES].
    CHABRIER P; CHEYMOL G; NGUYENTHANH THUONG ; RIOULT P
    C R Seances Soc Biol Fil; 1964; 158():2057-9. PubMed ID: 14282110
    [No Abstract]   [Full Text] [Related]  

  • 9. Reduction of secondary and tertiary phosphine oxides to phosphines.
    Hérault D; Nguyen DH; Nuel D; Buono G
    Chem Soc Rev; 2015 Apr; 44(8):2508-28. PubMed ID: 25714261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purinethiols as feedback inhibitors of purine synthesis in ascites tumor cells.
    LEPAGE GA; JONES M
    Cancer Res; 1961 Jun; 21():642-9. PubMed ID: 13760994
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of antitumor effect by "quantitative and multiple subcutaneous transplantation of ascites tumor cells" in mice.
    TAKAOKA M; ONUMA M; HATA T
    J Antibiot (Tokyo); 1960 Jan; 13():19-26. PubMed ID: 13855006
    [No Abstract]   [Full Text] [Related]  

  • 12. The influence of some anti-leukaemic chemicals on the proliferation of ascites tumour cells studied by the colchicine method.
    CARDINALI G; ROSATI-CARDINALI G; ALFIERI A
    Acta Unio Int Contra Cancrum; 1960; 16():563-6. PubMed ID: 13807659
    [No Abstract]   [Full Text] [Related]  

  • 13. Novel topoisomerase I inhibitors. Syntheses and biological evaluation of phosphorus substituted quinoline derivates with antiproliferative activity.
    Alonso C; Fuertes M; Martín-Encinas E; Selas A; Rubiales G; Tesauro C; Knudssen BK; Palacios F
    Eur J Med Chem; 2018 Apr; 149():225-237. PubMed ID: 29501943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [On the effect of cytostatic compounds and nicotinic acid amide on ascites tumor ribonuclease (n)].
    HILZ H; KLEMPIEN EJ
    Biochem Z; 1959; 331():563-76. PubMed ID: 14401841
    [No Abstract]   [Full Text] [Related]  

  • 15. A new mouse ascites tumour to be used as a screening tool.
    NEMETH L; KELLNER B
    Neoplasma; 1961; 8():337-43. PubMed ID: 14478985
    [No Abstract]   [Full Text] [Related]  

  • 16. Titration of the effects of a group of selected chemicals on the growth of ascites and solid forms of the Nelson mouse tumor.
    TARNOWSKI GS; BROSS ID
    Cancer Res; 1962 Jan; 22(1)Pt 2():136-53. PubMed ID: 13919696
    [No Abstract]   [Full Text] [Related]  

  • 17. [Studies on methods for the determination of anti-tumor properties of antibiotics and synthetic preparations. I. A rapid method of primary selection of Ehrlich ascites carcinoma cell inhibitors in vitro].
    AIZENMAN BIu; MANDRIK TP; SHVAIGER MO
    Mikrobiol Zh; 1959; 21(2)():49-56. PubMed ID: 13792221
    [No Abstract]   [Full Text] [Related]  

  • 18. Insertion of carbon fragments into P(III)-N bonds in aminophosphines and aminobis(phosphines): synthesis, reactivity, and coordination chemistry of resulting phosphine oxide derivatives. Crystal and molecular structures of (Ph(2)P(O)CH(2))(2)NR (R = Me, (n)Pr, (n)Bu), Ph(2)P(O)CH(OH)(n)()Pr, and cis-[MoO(2)Cl(2)((Ph(2)P(O)CH(2))(2)NEt-kappaO,kappaO)].
    Priya S; Balakrishna MS; Mague JT; Mobin SM
    Inorg Chem; 2003 Feb; 42(4):1272-81. PubMed ID: 12588166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies with ascites tumors in experimental chemotherapy. II. Performance in a screening situation.
    SASSENRATH EN; COSTA FM; GREENBERG DM
    Cancer Chemother Rep; 1961 Apr; 11():13-28. PubMed ID: 13746675
    [No Abstract]   [Full Text] [Related]  

  • 20. Amino Acid-Derived Bifunctional Phosphines for Enantioselective Transformations.
    Wang T; Han X; Zhong F; Yao W; Lu Y
    Acc Chem Res; 2016 Jul; 49(7):1369-78. PubMed ID: 27310293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.